Yes indeed ... and here is the first update!

Simon wrote: "We are looking forward to seeing the results of [the AIM-PD Ambroxol] study published early in 2020."

... and here are those results:

CPT article: Ambroxol in Parkinson's: Results of Phase ll Trial Published
Ambroxol in Parkinson's: Results of Phase ll Trial Published | The Cure Parkinson's Trust

Research paper: Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations - A Nonrandomized, Noncontrolled Trial
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial | Genetics and Genomics | JAMA Neurology | JAMA Network

(hat tip to Parkinsonjisung at HU for the links)